JP3054758B2 - Trauma composition - Google Patents

Trauma composition

Info

Publication number
JP3054758B2
JP3054758B2 JP9075080A JP7508097A JP3054758B2 JP 3054758 B2 JP3054758 B2 JP 3054758B2 JP 9075080 A JP9075080 A JP 9075080A JP 7508097 A JP7508097 A JP 7508097A JP 3054758 B2 JP3054758 B2 JP 3054758B2
Authority
JP
Japan
Prior art keywords
composition
alum
thickener
present
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP9075080A
Other languages
Japanese (ja)
Other versions
JPH10265391A (en
Inventor
恒太 高尾
周栄 岩本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP9075080A priority Critical patent/JP3054758B2/en
Publication of JPH10265391A publication Critical patent/JPH10265391A/en
Application granted granted Critical
Publication of JP3054758B2 publication Critical patent/JP3054758B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、外部侵襲によって
皮膚若しくは粘膜等に生じた外傷、例えば創傷,擦過傷
又は火傷等の傷口患部を殺菌、保護するための外傷組成
物に関する。より詳細には、殺菌剤、ミョウバン及び増
粘剤を含有する外傷用組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a wound composition for disinfecting and protecting wounds such as wounds, abrasions and burns caused by external insults on skin or mucous membranes. More particularly, it relates to a wound dressing composition containing a bactericide, alum and a thickener.

【0002】当該組成物によれば、創傷,擦過傷,火傷
又は褥瘡等といった皮膚損傷部を殺菌、保護し、患部に
細菌が感染することによって生じる化膿を有意に予防す
ることができる。更に本発明の組成物は、その収れん作
用により血液又はリンパ液の滲出によって湿潤した患部
を被覆保護、乾燥させ、外傷患部の早期修復、治癒をも
たらすことができる。
[0002] According to the composition, it is possible to sterilize and protect a damaged skin such as a wound, abrasion, burn or pressure sore, and to significantly prevent suppuration caused by infecting the affected part with bacteria. Furthermore, the composition of the present invention can protect and dry the affected area moistened by the exudation of blood or lymph due to the astringent action thereof, and can provide early repair and healing of the trauma affected area.

【0003】[0003]

【従来の技術】創傷又は擦過傷等の傷口を消毒し、また
細菌感染による化膿を防止するために従来から殺菌剤が
使用されている。かかる殺菌剤は低粘度のものが多いた
め、従来、流れ落ちたり、衣類などに付着したりして効
力が長続きしない等といった問題があった。このため、
殺菌剤と増粘剤とを組み合わせることにより適用部位に
長期間滞留させ、殺菌効果を持続させる工夫が為されて
いる。
2. Description of the Related Art Disinfectants have conventionally been used to disinfect wounds such as wounds or abrasions and to prevent suppuration due to bacterial infection. Since many of these disinfectants have a low viscosity, there has been a problem that the efficacy of the disinfectant does not last for a long time because the disinfectant runs down or adheres to clothes or the like. For this reason,
A combination of a bactericide and a thickener allows the bactericidal agent to stay at the application site for a long period of time to maintain the bactericidal effect.

【0004】外傷用殺菌剤として汎用されているクロル
ヘキシジン等のグアニジン系殺菌剤は、グラム陽性菌及
びグラム陰性菌に広く抗菌作用を現し、第四級アンモニ
ウム系、フェニール系あるいはヨード製剤などといった
他の殺菌剤よりも強い殺菌効果を示すことが知られてい
る。
[0004] Guanidine-based germicides such as chlorhexidine, which are widely used as wound germicides, exhibit an antibacterial effect widely on Gram-positive bacteria and Gram-negative bacteria, and can be used in other germicides such as quaternary ammonium, phenyl or iodine preparations. It is known to exhibit a stronger bactericidal effect than bactericides.

【0005】しかし、当該グアニジン系殺菌剤の場合、
その殺菌効果に持続性を持たせるべく増粘剤を配合する
と、却ってその殺菌効果が著しく軽減してしまうという
問題がある。
However, in the case of the guanidine fungicide,
If a thickening agent is added to make the bactericidal effect persistent, there is a problem that the bactericidal effect is considerably reduced.

【0006】また、従来の外傷用薬剤には、殺菌効果の
みを持たせたものや収れん効果のみを持たせたものはあ
るが、これらは傷口に対する保護や感染防止及び早期治
癒効果の観点からは十分ではない。
[0006] In addition, some conventional wound medicines have only a bactericidal effect or only a convergence effect. However, these are not suitable for protecting wounds, preventing infection and early healing effect. Not enough.

【0007】従って、殺菌消毒処置と収れん・止血処
置、及び化膿防止処置を同時に実現できる外用剤、更に
は処置後の患部が着色せず透明で傷口が目立たない外用
剤が望まれているのが実情である。
[0007] Therefore, there is a need for an external preparation which can simultaneously realize a disinfecting treatment, an astringent / hemostatic treatment, and an anti-suppuration treatment, and further, an external preparation which does not discolor the affected part after treatment and is transparent and has no noticeable wound. It is a fact.

【0008】[0008]

【発明が解決しようとする課題】本発明は、殺菌剤とし
てグアニジン系殺菌剤を含有する外傷用組成物であっ
て、殺菌効果を低減させることなく患部に滞留させ得、
かつ収れん効果をも持ち合わせた外傷用組成物を提供す
ることを目的とする。また本発明は、緑膿菌等の細菌感
染による患部の化膿化を有意に防止し、更に患部の止
血、乾燥化を促進して傷口の早期修復、治癒をもたらす
ことのできる外傷用組成物を提供することを目的とす
る。
DISCLOSURE OF THE INVENTION The present invention relates to a trauma composition containing a guanidine fungicide as a fungicide, which can be retained in an affected part without reducing the bactericidal effect.
An object of the present invention is to provide a composition for trauma having a convergence effect. Further, the present invention provides a composition for trauma which can significantly prevent purulence of an affected part due to bacterial infection such as Pseudomonas aeruginosa, further promote hemostasis and desiccation of the affected part, and can quickly repair and heal the wound. The purpose is to provide.

【0009】[0009]

【課題を解決するための手段】本発明者らは、創傷・擦
過傷用組成物の開発に際して、グアニジン系殺菌剤に増
粘剤を配合すると、殺菌組成物の患部への滞留効果は向
上するものの殺菌効果が著しく低減してしまうという問
題に突き当たった。そこでこの問題を解決すべく、鋭意
研究を重ねていたところ、グアニジン系殺菌剤と増粘剤
との混合組成物にミョウバンを配合することにより、グ
アニジン系殺菌剤の殺菌効果の低減が有意に抑制され、
加えてミョウバンの収れん作用及び増粘剤による殺菌組
成物の滞留効果によって外傷治療用組成物として種々の
優れた特性を呈することを見出した。更に該組成物は、
患部を着色させることなく透明であり傷口を目立たせな
いといった外用剤として望ましい特徴を有することを確
認してして本発明を完成するに至った。
Means for Solving the Problems In the development of a composition for wounds and abrasions, the present inventors have found that if a thickening agent is added to a guanidine fungicide, the effect of retaining the fungicidal composition in the affected area is improved. A problem has been encountered that the sterilization effect is significantly reduced. In order to solve this problem, we have been conducting intensive research.By adding alum to a mixed composition of a guanidine fungicide and a thickener, the reduction of the germicidal effect of the guanidine fungicide is significantly suppressed. And
In addition, the present inventors have found that the composition exhibits various excellent properties as a composition for treating wounds due to the astringent action of alum and the retention effect of the sterilizing composition by the thickener. The composition further comprises:
The present invention has been completed by confirming that it has the desirable characteristics as an external preparation such that the affected part is transparent without coloring the wound and the wound is not noticeable.

【0010】即ち、本発明は、下記のいずれかの態様か
らなる外傷用組成物である。
That is, the present invention is a trauma composition comprising any one of the following embodiments.

【0011】(1) グアニジン系殺菌剤、ミョウバン及び
増粘剤を含有することを特徴とする外傷用組成物。
(1) A composition for wounds comprising a guanidine fungicide, alum and a thickener.

【0012】(2) グアニジン系殺菌剤が、塩酸クロルヘ
キシジン又はグルコン酸クロルヘキシジンから選択され
る少なくとも1種であることを特徴とする上記(1)記載
の外傷 用組成物。
(2) The wound dressing composition according to the above (1), wherein the guanidine fungicide is at least one selected from chlorhexidine hydrochloride and chlorhexidine gluconate.

【0013】(3) 増粘剤が、セルロース系、アクリル酸
系又はアルギン酸系に属する増粘剤のいずれか少なくと
も1種であることを特徴とする上記(1)又は(2)記載の外
傷用組成物。
(3) The wound dressing according to the above (1) or (2), wherein the thickener is at least one selected from the group consisting of cellulose, acrylic acid and alginic acid. Composition.

【0014】(4) 組成物100重量%あたり、グアニジ
ン系殺菌剤を0.1〜0.2重量%、ミョウバンを10
〜90重量%及び増粘剤を0.1〜5重量%の割合で含
有することを特徴とする、上記(1)乃至(3)のいずれかに
記載の外傷用組成物。
(4) Per 100% by weight of the composition, 0.1 to 0.2% by weight of a guanidine fungicide and 10% of alum are used.
The composition for trauma according to any one of the above (1) to (3), which comprises about 90% by weight and 0.1 to 5% by weight of a thickener.

【0015】[0015]

【発明の実施の形態】本発明で用いられる殺菌剤は、グ
アニジン系殺菌剤であれば特に制限されないが、通常ク
ロルヘキシジンの酸性塩、例えばクロルヘキシジンの二
塩酸塩若しくはその二グルコン酸塩、つまり塩酸クロル
ヘキシジン又はグルコン酸クロルヘキシジンが例示され
る。
BEST MODE FOR CARRYING OUT THE INVENTION The fungicide to be used in the present invention is not particularly limited as long as it is a guanidine fungicide. Usually, an acid salt of chlorhexidine, for example, chlorhexidine dihydrochloride or its digluconate, ie, chlorhexidine hydrochloride. Or chlorhexidine gluconate.

【0016】また本発明で用いられるミョウバンには、
一般式: MI 2SO4III 2(SO4)3・24H2O、又はMI
III(SO4)2・12H2O 〔式中、MIは一価の陽イオンを示し、MIIIは三価の金
属イオンを示す。〕で示される塩若しくはその複塩、ま
たは上記塩から結晶水を除去した無水塩が広く包含され
る。
The alum used in the present invention includes:
General formula: M I 2 SO 4 M III 2 (SO 4) 3 · 24H 2 O, or M I M
III (SO 4) in 2 · 12H 2 O [Formula, M I represents a monovalent cation, M III represents a trivalent metal ion. Or a double salt thereof, or an anhydrous salt obtained by removing water of crystallization from the above salt.

【0017】ここで一価の陽イオンとしては、例えばT
+、Cs+、Rb+、K+、Na+、Li+、Ag+、NH4
+、アルキルアンモニウムイオン等が挙げられ、また三
価の金属イオンとしては、例えばAl3+、Ti3+
3+、Cr3+、Mn3+、Fe3+、Co3+、Fe3+、Ga
3+、In3+、Ir3+、Rh3+等が挙げられる。
Here, as the monovalent cation, for example, T
l + , Cs + , Rb + , K + , Na + , Li + , Ag + , NH 4
+ , Alkyl ammonium ions and the like. Examples of the trivalent metal ions include, for example, Al 3+ , Ti 3+ ,
V 3+ , Cr 3+ , Mn 3+ , Fe 3+ , Co 3+ , Fe 3+ , Ga
3+ , In 3+ , Ir 3+ , Rh 3+ and the like.

【0018】より具体的には、硫酸アルミニウムカリウ
ム〔Al2(SO4)3・K2SO4・24H2O又はAlK(SO4)2・12H2O:Kミ
ョウバン〕、硫酸アルミニウムナトリウム〔Al2(SO4)3
Na2SO4・24H2O又はAlNa(SO4)2・12H2O:Naミョウバ
ン〕、硫酸アルミニウムセシウム(Csミョウバン)、
硫酸アルミニウムアンモニウム(アンモニウムミョウバ
ン)、硫酸鉄ナトリウム(鉄ナトリウムミョウバン)等
が挙げられるが、好ましくは硫酸アルミニウムカリウム
であり、通常、一般的に日本薬局方で規定されている硫
酸アルミニウムカリウム〔AlK(SO4)2・12H2O〕を99.
5%以上包含するものが用いられる。
More specifically, potassium aluminum sulfate [Al 2 (SO 4 ) 3 · K 2 SO 4 · 24H 2 O or AlK (SO 4 ) 2 · 12H 2 O: K alum], sodium aluminum sulfate [Al 2 (SO 4 ) 3
Na 2 SO 4 · 24H 2 O or AlNa (SO 4 ) 2 · 12H 2 O: Na alum], aluminum cesium sulfate (Cs alum),
Examples thereof include ammonium ammonium sulfate (ammonium alum), sodium iron sulfate (iron sodium alum) and the like, preferably potassium aluminum sulfate, and usually aluminum potassium sulfate [AlK (SO 4 ) 2・ 12H 2 O].
Those containing 5% or more are used.

【0019】本発明で用いられる増粘剤としては、適当
な処理によって粘性を呈し増粘効果を発揮するものであ
れば特に制限されず、例えば化粧品、食品又は医薬品等
の分野で増粘剤、濃化剤、分散剤、懸濁剤、乳化剤、ゲ
ル化剤、バインダー等として用いられる剤を広く挙げる
ことができる。具体的には例えば、アルギン酸系、アク
リル酸系、セルロース系に属する各種の増粘剤が挙げら
れる。
The thickener used in the present invention is not particularly limited as long as it exhibits viscosity and exerts a thickening effect by an appropriate treatment. For example, thickeners in the fields of cosmetics, foods, pharmaceuticals, etc. Agents used as thickeners, dispersants, suspending agents, emulsifiers, gelling agents, binders, and the like can be widely mentioned. Specific examples include alginic acid-based, acrylic acid-based, and cellulose-based thickeners.

【0020】これらの系に属する増粘剤であれば特に制
限はないが、通常具体的には、アルギン酸系の増粘剤と
しては、アルギン酸の塩又はエステルが挙げられ、より
具体的には、アルギン酸ナトリウム、アルギン酸プロピ
レングリコールが例示される。
Although there is no particular limitation as long as it is a thickener belonging to these systems, usually, specific examples of the alginic acid-based thickener include alginic acid salts or esters, and more specifically, Examples include sodium alginate and propylene glycol alginate.

【0021】またアクリル酸系の増粘剤としては、アク
リル酸を主としてこれに少量のアリルショ糖等を配した
共重合体である酸性高分子化合物、具体的にはカルボキ
シビニルポリマー、又はポリアクリルアミドが例示され
る。
As the acrylic acid-based thickener, an acidic high molecular compound which is a copolymer of acrylic acid and a small amount of allyl sucrose or the like, specifically, carboxyvinyl polymer or polyacrylamide is used. Is exemplified.

【0022】更に、セルロース系に属する増粘剤として
は、水溶性セルロース誘導体、例えばセルロースのヒド
ロキシアルキルエーテル若しくはカルボキシアルキルエ
ーテルまたはそれらの塩が挙げられる。尚、ここでアル
キル基としては炭素数1乃至5の低級アルキル基が挙げ
られる。セルロースのヒドロキシアルキルエーテルとし
ては、より具体的にはヒドロキシメチルセルロース、ヒ
ドロキシエチルセルロース又はヒドロキシプロピルセル
ロースが、またセルロースのカルボキシアルキルエーテ
ルとしては、カルボキシメチルセルロースが例示され
る。塩としてはナトリウム又はカリウムなどのアルカリ
金属塩が挙げられ、好適にはカルボキシメチルセルロー
スのナトリウム塩又はカリウム塩である。
Further, examples of the thickener belonging to the cellulosic type include water-soluble cellulose derivatives such as hydroxyalkyl ether or carboxyalkyl ether of cellulose or salts thereof. Here, the alkyl group includes a lower alkyl group having 1 to 5 carbon atoms. More specifically, examples of the hydroxyalkyl ether of cellulose include hydroxymethyl cellulose, hydroxyethyl cellulose and hydroxypropyl cellulose, and examples of the carboxyalkyl ether of cellulose include carboxymethyl cellulose. Examples of the salt include an alkali metal salt such as sodium or potassium, and preferably a sodium or potassium salt of carboxymethylcellulose.

【0023】増粘剤は、配合する殺菌剤の種類、本発明
の組成物の適用場所又は用途などに応じて、上記各種増
粘剤の中から適宜選択、採用されるが、好ましくは、ア
ルギン酸ナトリウム、ポリアクリル酸アミドである。な
お、これらは単独で若しくは二種以上を組み合わせて用
いることもできる。
The thickener is appropriately selected and employed from the above-mentioned various thickeners according to the kind of the disinfectant to be blended, the application place or application of the composition of the present invention, etc., and preferably, alginic acid is used. Sodium and polyacrylamide. These can be used alone or in combination of two or more.

【0024】なお、前述するグアニジン系殺菌剤、ミョ
ウバン及び増粘剤はいずれも現在市販され若しくは将来
入手可能となるものを用いることができる。
The above-mentioned guanidine fungicide, alum and thickener may be those which are currently commercially available or will be available in the future.

【0025】本発明の組成物は、前述の三成分を含有す
るものであれば、その組成を特に制限するものではない
が、当該組成物100重量%あたり、通常グアニジン系
殺菌剤を0.1〜0.2重量%、ミョウバンを10〜9
0重量%及び増粘剤を0.1〜5重量%の割合で含有し
ていることが好ましい。より好ましい配合割合は、グア
ニジン系殺菌剤が0.1〜0.2重量%、ミョウバンが
20〜80重量%及び増粘剤が0.2〜4重量%であ
り、一層好ましくは、グアニジン系殺菌剤が0.1〜
0.2重量%、ミョウバンが40〜70重量%及び増粘
剤が0.2〜3重量%である。
The composition of the present invention is not particularly limited as long as it contains the above-mentioned three components. Usually, a guanidine fungicide is used in an amount of 0.1% per 100% by weight of the composition. 0.2% by weight, alum 10-9
It is preferable to contain 0% by weight and 0.1 to 5% by weight of a thickener. A more preferable mixing ratio is 0.1 to 0.2% by weight of the guanidine fungicide, 20 to 80% by weight of the alum, and 0.2 to 4% by weight of the thickener, and more preferably, the guanidine fungicide. Agent is 0.1 ~
0.2% by weight, alum 40-70% by weight and thickener 0.2-3% by weight.

【0026】なお、本発明の組成物は、本発明の効果を
損なわない限り上記成分に加えて任意の成分を含有して
いてもよい。任意の成分としては、例えば外用剤等の医
薬品に用いられる担体、基剤若しくは各種の添加剤が挙
げられ、具体的には、注射用蒸留水,生理食塩水等の担
体、親水性ワセリン等の乳剤性基剤,油脂類,ろう類等
の軟膏用基剤、安定剤,保存剤,溶解補助剤,乳化剤,
懸濁化剤又は無痛化剤等の添加剤等が例示される。
The composition of the present invention may contain optional components in addition to the above components as long as the effects of the present invention are not impaired. Examples of the optional component include carriers, bases, and various additives used in pharmaceuticals such as external preparations. Specific examples include carriers such as distilled water for injection and physiological saline, and hydrophilic petrolatum and the like. Emulsion bases, bases for ointments such as fats and oils, waxes, etc., stabilizers, preservatives, dissolution aids, emulsifiers,
Examples thereof include additives such as a suspending agent and a soothing agent.

【0027】本発明の組成物は、物理的作用もしくは化
学的作用等の外部侵襲によって生じた皮膚若しくは粘膜
の損傷部、具体的には切傷,裂傷,挫傷などの創傷、擦
過傷、火傷ひいては褥瘡等の外傷患部に外用剤として用
いられるものである。従って、本発明の組成物はその態
様に特に制限されることなく一般に外用剤に用いられる
あらゆる態様が広く採用され、適用場所又は用途等に応
じて適当な剤型に調製することができる。剤型として、
具体的には液剤、懸濁剤、乳剤、ローション剤、軟膏
剤、クリーム剤、スプレー剤、フォーム剤、貼付剤、硬
膏剤などが例示されるが、好ましくは軟膏剤、クリーム
剤である。
The composition of the present invention can be used for damaged skin or mucous membranes caused by external invasion such as physical action or chemical action, specifically wounds such as cuts, lacerations and bruises, abrasions, burns and pressure ulcers. It is used as an external preparation for the wound affected area. Therefore, the composition of the present invention is not particularly limited to that aspect, and all aspects generally used for external preparations are widely adopted, and can be prepared into an appropriate dosage form according to the application place or use. As a dosage form,
Specific examples include liquids, suspensions, emulsions, lotions, ointments, creams, sprays, foams, patches, plasters, and the like, and preferably ointments and creams.

【0028】本発明の外傷用組成物は、優れた殺菌作用
を有するため創傷,擦過傷,火傷又は褥瘡等の皮膚損傷
部を有意に殺菌消毒することができるとともに、収れん
・止血作用及び薬物滞留作用を持ち合わせるため、血液
やリンパ液の滲出により浸潤した患部を、該組成物が被
膜を形成することにより保護し乾燥させ、これにより患
部の早期修復、早期治癒を促すことができる。
Since the composition for wounds of the present invention has an excellent bactericidal action, it can significantly disinfect and disinfect skin wounds such as wounds, abrasions, burns or pressure ulcers, as well as astringent / hemostatic action and drug retention action. The composition protects and infects the affected area by infiltration due to the exudation of blood or lymph, thereby promoting early repair and early healing of the affected area.

【0029】人体や動物における傷口には緑膿菌(Pseu
domonas aeruginosa)が多く存在し、これらが傷口の化
膿の原因となっている。本発明の外傷用組成物が対象と
する細菌は特に限定されることなく、広く化膿菌を対象
とすることができるが、上記するように傷口の化膿をも
たらす緑濃菌に対する殺菌作用がとりわけ優れているた
め、化膿化の防止剤として極めて有用である。さらに、
本発明の組成物は、塗布適用後透明であるため、患部が
目立たないという外用剤として好ましい特徴をも有して
いる。
[0029] Pseudomonas aeruginosa ( Pseu
domonas aeruginosa ) is abundant and these are the causes of suppuration of the wound. Bacteria targeted by the trauma composition of the present invention are not particularly limited, and can be broadly targeted against Pseudomonas aeruginosa, but are particularly excellent in bactericidal action against Pseudomonas aeruginosa causing suppuration of the wound as described above. Therefore, it is extremely useful as an agent for preventing suppuration. further,
Since the composition of the present invention is transparent after application and application, it also has a characteristic that the affected area is inconspicuous and is preferable as an external preparation.

【0030】[0030]

【実施例】以下、本発明を実施例及び実験例によって更
に詳細に説明するが、本発明は当該実施例等によって何
ら制限されるものではない。尚、以下記載する%は特に
断らない限り、重量%を意味する。
EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples, but the present invention is not limited to the Examples and the like. In addition,% described below means% by weight unless otherwise specified.

【0031】実施例1 塩酸クロルヘキシジン、ミョウバン(硫酸アルミニウム
カリウム99.5%含有:大明化学工業社製)、アルギ
ン酸ナトリウム及びポリアクリル酸アミドを精製水に溶
解して、塩酸クロルヘキシジン0.2%、ミョウバン6
5%、アルギン酸ナトリウム及びポリアクリル酸アミド
合計2.75%を含有する本発明の外傷用組成物(軟膏
剤)を調製した。
Example 1 Chlorhexidine hydrochloride, alum (containing 99.5% of aluminum potassium sulfate: manufactured by Daimei Chemical Co., Ltd.), sodium alginate and polyacrylamide were dissolved in purified water, and 0.2% of chlorhexidine hydrochloride and alum were dissolved. 6
A trauma composition (ointment) of the present invention containing 5%, a total of 2.75% of sodium alginate and polyacrylamide was prepared.

【0032】実施例2 ミョウバンの配合量が5〜95%の範囲となるように調
製する以外は、実施例1と同様にして本発明の外傷用組
成物を調製した。
Example 2 A wound composition of the present invention was prepared in the same manner as in Example 1, except that the amount of alum was adjusted to be in the range of 5 to 95%.

【0033】実験例1 緑膿菌(Pseudomonas aeruginosa:KPB36)を対象
として、実施例1記載の処方に従って調製した0.1%
又は0.2%の塩酸クロルヘキシジンを含有する本発明
外傷用組成物(軟膏剤)の殺菌効果を調べた。
EXPERIMENTAL EXAMPLE 1 0.1% of Pseudomonas aeruginosa (KPB36) prepared according to the formulation described in Example 1 for Pseudomonas aeruginosa.
Alternatively, the bactericidal effect of the trauma composition (ointment) of the present invention containing 0.2% of chlorhexidine hydrochloride was examined.

【0034】なお、比較対照用の組成物として、(1)0.
1%又は0.2% 塩酸クロルヘキシジン懸濁液(溶
媒:精製水)、(2)65% ミョウバン水溶液(溶媒:
精製水)、(3)0.1%又は0.2% 塩酸クロルヘキシ
ジン及び2.75% 増粘剤(ポリアクリル酸アミド+
アルギン酸ナトリウム)含有軟膏剤を用いて同様に、緑
膿菌に対する殺菌効果を調べた。
As a composition for comparison, (1) 0.
1% or 0.2% chlorhexidine hydrochloride suspension (solvent: purified water), (2) 65% alum aqueous solution (solvent:
Purified water), (3) 0.1% or 0.2% chlorhexidine hydrochloride and 2.75% thickener (polyacrylamide +
Similarly, the bactericidal effect against Pseudomonas aeruginosa was examined using an ointment containing sodium alginate).

【0035】<実験方法>下記の方法によって、各組成
物の殺菌効果を調べた。
<Experimental method> The bactericidal effect of each composition was examined by the following method.

【0036】1. 菌の原液(細胞数1×108個)を調整
する。
1. Prepare a stock solution of bacteria (1 × 10 8 cells).

【0037】2. 上記菌原液を各試験組成物10mlあ
たり100μlづつ接種し、よく混和する。
2. Inoculate the bacterial stock solution at 100 μl per 10 ml of each test composition and mix well.

【0038】3. 各混和・反応時間毎(〜180分)
に、上記 2.の試料から50μlを採取して5mlの7
%ポリソルベート80・生理食塩水溶液に接種し、反応
を停止する。
3. For each mixing / reaction time (up to 180 minutes)
Then, 50 µl was collected from the sample of 2 above and 5 ml of 7
% Polysorbate 80 in physiological saline solution to stop the reaction.

【0039】4. 反応を停止させた試料をSCDLP寒
天平板培地(精製水1リットルあたり、ポリペプトン1
5g、ポリペプトンS 5g、塩化ナトリウム5g、寒
天15g、レシチン1g、ポリソルベート80 7gを含
む)に蒔いて、30℃で一昼夜培養する。
4. The reaction-stopped sample was placed on a SCDLP agar plate medium (1 liter of purified water, 1 peptone per liter of purified water).
5 g, polypeptone S 5 g, sodium chloride 5 g, agar 15 g, lecithin 1 g, polysorbate 807 g) and culture at 30 ° C. overnight.

【0040】5. 平板培地上に現れたコロニーの数をカ
ウントする。
5. Count the number of colonies appearing on the plate medium.

【0041】結果を図1(塩酸クロルヘキシジン0.1
%使用)及び図2(塩酸クロルヘキシジン0.2%使
用)に示す。尚、図中縦軸はコロニーの数を、横軸は組
成物と菌との混和・反応時間(分)を示す。また、図中
各線グラフは、−×−が本発明の外傷用組成物(塩酸ク
ロルヘキシジン+ミョウバン+増粘剤)、−■−が塩酸
クロルヘキシジン(対照試料(1))、−▲−がミョウバ
ン(対照試料(2))、−◆−塩酸クロルヘキシジン+増
粘剤(対照試料(3))を示す。
The results are shown in FIG. 1 (chlorhexidine hydrochloride 0.1
%) And FIG. 2 (using 0.2% of chlorhexidine hydrochloride). In the figure, the vertical axis indicates the number of colonies, and the horizontal axis indicates the mixing / reaction time (minute) between the composition and the bacteria. Further, in the respective line graphs in the figure, -x- indicates the composition for wounds of the present invention (chlorhexidine hydrochloride + alum + thickener),-■-indicates chlorhexidine hydrochloride (control sample (1)), and-▲-indicates alum ( Control sample (2)) and-◆ -chlorhexidine hydrochloride + thickener (control sample (3)) are shown.

【0042】この結果から明らかなように、塩酸クロル
ヘキシジンに増粘剤を配合すると、塩酸クロルヘキシジ
ンの殺菌効果が著しく低下する。しかし、それにミョウ
バンを配合すると殺菌作用が回復し、増粘剤の配合によ
る殺菌効果の軽減が有意に抑制できる。従って本発明の
組成物は、ミョウバンによる収れん・止血作用を有し、
かつ該組成物を患部に滞留させて持続的な殺菌作用を発
揮できることに加えて、優れた殺菌効果を有する外傷用
組成物である。特に本発明の組成物は、緑膿菌に対する
殺菌効果に優れるため、化膿防止剤として有用である。
As is evident from the results, when a thickener is added to chlorhexidine hydrochloride, the bactericidal effect of chlorhexidine hydrochloride is remarkably reduced. However, when alum is added thereto, the bactericidal action is restored, and the reduction of the bactericidal effect by the addition of the thickener can be significantly suppressed. Therefore, the composition of the present invention has an astringent and hemostatic action by alum,
In addition, the composition is a trauma composition having an excellent bactericidal effect, in addition to having the composition stay in an affected area and exhibiting a continuous bactericidal effect. In particular, the composition of the present invention is useful as a suppuration inhibitor since it has an excellent bactericidal effect against Pseudomonas aeruginosa.

【0043】また、塩酸クロルヘキシジンに代えてグル
コン酸クロルヘキシジンを用いて同様な実験を行った場
合も同様な結果が得られた。
Similar results were obtained when a similar experiment was performed using chlorhexidine gluconate instead of chlorhexidine hydrochloride.

【0044】実験例2 ミョウバンの配合量と使用感
との関係 実施例2で調製した外傷用組成物(0.2%塩酸クロル
ヘキシジン、5〜95%ミョウバン、2.75%アルギ
ン酸ナトリウム+ポリアクリル酸アミド含有)を用いて
ミョウバンの配合量と使用感との関係を調べた。
EXPERIMENTAL EXAMPLE 2 Relationship between Alum Blending Amount and Feeling of Use A wound composition prepared in Example 2 (0.2% chlorhexidine hydrochloride, 5-95% alum, 2.75% sodium alginate + polyacrylic acid) (Containing amide) was used to investigate the relationship between the amount of alum and the feeling of use.

【0045】具体的には、任意に選択したボランティア
40人を対象として各組成物を顔、手、足部に1mlず
つ塗布してもらい、塗布した際のザラつき感、ベトつき
感、付着性、止血力、及び塗布した患部の透明感を「良
い、やや良い、普通、やや悪い、悪い」の5段階で評価
してもらった。結果を表1に示す。なお、表中、○、
△、×はそれぞれ次の基準に従うものとする。
Specifically, 1 ml of each composition was applied to the face, hands and feet of 40 voluntarily selected volunteers, and the applied composition was rough, sticky, and adherent. , Hemostatic power, and transparency of the applied affected area were evaluated on a five-point scale of "good, moderately good, normal, slightly poor, and bad". Table 1 shows the results. In the table, ○,
Δ and × are based on the following standards.

【0046】 ○:「悪い」及び「やや悪い」が、いずれも0%であ
る。
:: Both “bad” and “slightly bad” are 0%.

【0047】 △:「悪い」が40%以下、或いは「やや悪い」が40
%以下 ×:「悪い」が40%以上 或いは「やや悪い」が40
%以上
Δ: “bad” is 40% or less, or “slightly bad” is 40
% Or less ×: “bad” is 40% or more or “slightly bad” is 40
%that's all

【0048】[0048]

【表1】 [Table 1]

【0049】これらの結果から、本発明の外傷用組成物
は、ミョウバンを配合することによりザラつきやベトつ
き感等の触感上の不快感が軽減され、更に殺菌性組成物
の付着性及び止血力が向上することがわかる。
From these results, it can be seen that the trauma composition of the present invention can reduce the tactile discomfort such as roughness and stickiness by adding alum, and furthermore, the adhesiveness and hemostasis of the bactericidal composition. It can be seen that the power is improved.

【図面の簡単な説明】[Brief description of the drawings]

【図1】塩酸クロルヘキシジン0.1%を含む本発明の
外傷用組成物(軟膏:図中−×−で示す。)の緑膿菌に
対する殺菌効果を、塩酸クロルヘキシジン懸濁液(図中
−■−で示す。)、ミョウバン水溶液(図中−▲−で示
す。)及び塩酸クロルヘキシジン+増粘剤(軟膏:図中
−◆−で示す。)の各比較対照組成物と比較した図であ
る。縦軸はコロニー数を、横軸は菌と各組成物の混合・
反応時間(分)を示す。
FIG. 1 shows the bactericidal effect of the trauma composition of the present invention containing 0.1% chlorhexidine hydrochloride (ointment: indicated by -x- in the figure) on Pseudomonas aeruginosa, by using a chlorhexidine hydrochloride suspension (-■ in the figure). It is a figure which compared with each comparative control composition of alum aqueous solution (indicated by-in the figure), chlorhexidine hydrochloride + thickener (ointment: indicated by-in the figure). The vertical axis is the number of colonies, and the horizontal axis is the mixture of bacteria and each composition.
The reaction time (min) is shown.

【図2】塩酸クロルヘキシジン0.2%を含む本発明の
外傷用組成物(軟膏:図中−×−で示す。)の緑膿菌に
対する殺菌効果を、塩酸クロルヘキシジン懸濁液(図中
−■−で示す。)、ミョウバン水溶液(図中−▲−で示
す。)及び塩酸クロルヘキシジン+増粘剤(軟膏:図中
−◆−で示す。)の各比較対照組成物と比較した図であ
る。縦軸はコロニー数を、横軸は菌と各組成物の混合・
反応時間(分)を示す。
FIG. 2 shows the bactericidal effect of the trauma composition of the present invention containing 0.2% of chlorhexidine hydrochloride (ointment: indicated by -x- in the figure) on Pseudomonas aeruginosa. It is a figure which compared with each comparative control composition of alum aqueous solution (indicated by-in the figure), chlorhexidine hydrochloride + thickener (ointment: indicated by-in the figure). The vertical axis is the number of colonies, and the horizontal axis is the mixture of bacteria and each composition.
The reaction time (min) is shown.

フロントページの続き (51)Int.Cl.7 識別記号 FI A61P 31/02 A61P 31/02 (58)調査した分野(Int.Cl.7,DB名) A61K 33/06 A61K 31/155 A61K 47/30 Continued on the front page (51) Int.Cl. 7 identification code FI A61P 31/02 A61P 31/02 (58) Investigated field (Int.Cl. 7 , DB name) A61K 33/06 A61K 31/155 A61K 47 / 30

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】グアニジン系殺菌剤、ミョウバン及び増粘
剤を含有することを特徴とする外傷用組成物。
1. A composition for trauma comprising a guanidine fungicide, alum and a thickener.
【請求項2】グアニジン系殺菌剤が、塩酸クロルヘキシ
ジン又はグルコン酸クロルヘキシジンから選択される少
なくとも1種であることを特徴とする請求項1記載の外
傷用組成物。
2. The composition for wounds according to claim 1, wherein the guanidine fungicide is at least one selected from chlorhexidine hydrochloride and chlorhexidine gluconate.
【請求項3】増粘剤がセルロース系、アクリル酸系又は
アルギン酸系に属する増粘剤のいずれか少なくとも1種
であることを特徴とする請求項1又は2記載の外傷用組
成物。
3. The wound dressing composition according to claim 1, wherein the thickener is at least one selected from the group consisting of cellulose, acrylic acid and alginic acid.
【請求項4】組成物100重量%あたり、グアニジン系
殺菌剤を0.1〜0.2重量%、ミョウバンを10〜9
0重量%及び増粘剤を0.1〜5重量%の割合で含有す
ることを特徴とする、請求項1乃至3のいずれかに記載
の外傷用組成物。
4. A guanidine fungicide of 0.1 to 0.2% by weight and alum of 10 to 9% by weight per 100% by weight of the composition.
The wound dressing composition according to any one of claims 1 to 3, comprising 0% by weight and 0.1 to 5% by weight of a thickener.
JP9075080A 1997-03-27 1997-03-27 Trauma composition Expired - Fee Related JP3054758B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9075080A JP3054758B2 (en) 1997-03-27 1997-03-27 Trauma composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9075080A JP3054758B2 (en) 1997-03-27 1997-03-27 Trauma composition

Publications (2)

Publication Number Publication Date
JPH10265391A JPH10265391A (en) 1998-10-06
JP3054758B2 true JP3054758B2 (en) 2000-06-19

Family

ID=13565857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9075080A Expired - Fee Related JP3054758B2 (en) 1997-03-27 1997-03-27 Trauma composition

Country Status (1)

Country Link
JP (1) JP3054758B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777648B1 (en) * 2015-12-08 2017-09-13 주식회사 반도호이스트 Bridge for sliding type

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809310B1 (en) * 2000-05-26 2004-02-13 Centre Nat Rech Scient USE OF BIGUANIDE DERIVATIVES FOR MANUFACTURING A MEDICINAL PRODUCT HAVING A HEALING EFFECT
KR100372040B1 (en) * 2002-03-15 2003-02-14 메디코룩스(주) A pharmaceutical composition for wound healing
JP4712380B2 (en) * 2002-07-26 2011-06-29 三笠製薬株式会社 Topical preparation
KR20160096678A (en) * 2013-12-12 2016-08-16 이노베이션 테크놀로지스, 인코포레이티드 Materials and methods for controlling infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777648B1 (en) * 2015-12-08 2017-09-13 주식회사 반도호이스트 Bridge for sliding type

Also Published As

Publication number Publication date
JPH10265391A (en) 1998-10-06

Similar Documents

Publication Publication Date Title
JP7054212B2 (en) A novel fast-adhesive thin-film forming composition as an effective wound care procedure
EP2763665B1 (en) Antimicrobial compositions and methods employing same
US5942218A (en) Anti-infective material
Kaye Topical antibacterial agents
JP2763492B2 (en) Ointment for wound treatment
JP2003511473A (en) Topical, non-cytotoxic, thixotropic antibacterial hydrogel
US6348190B1 (en) Pharmaceutical compositions with antimicrobial activity
CN102970995A (en) Stable antiseptic compositions and methods
US6521243B2 (en) Ionic chitosan -iodine complexes: antiseptic hydrogels and wound healing promoters
US20220142154A1 (en) Topical antiseptic system
SE1650162A1 (en) Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants.
JP3054758B2 (en) Trauma composition
CN108619550A (en) A kind of hydrogel and preparation method thereof
US6923990B2 (en) Stabilized silver-ion amine complex compositions and methods
JP2935339B2 (en) External disinfectant
WO1989000850A1 (en) Pharmaceutical composition
WO2005107774A1 (en) Pharmaceutical wound healing composition
US20230240302A1 (en) Antimicrobial silver coordination complexes
Lawrence Medicated tulle dressings
Selwyn The topical treatment of skin infection
AU704571B2 (en) Topical preparation
WO2001000251A1 (en) Antiseptic and antimicrobial pharmaceutical preparation of feracrylum
JP2022170269A (en) Skin coating formulation with sterilization function
WO1996014859A1 (en) Topical preparation
GERACI New iodine compound for degerming skin surface

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090414

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 10

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110414

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130414

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130414

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140414

Year of fee payment: 14

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees